Good to hear Dep Docetaxel Phase 2 trial dosing of cohort has began in combination
with nintedanib
For those that are not aware......Starpharma is conducting 2 parallel studies with dep docetaxel.
One with Dep Docetaxel alone for several indications and the other in combination with nintedanib focusing on lung cancer
Quarterly Report, page-41
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
